Hydromorphone

What is Hydromorphone? 1

  • Semi-synthetic opioid analgesic derived from morphine.
  • Used for the management of moderate to severe pain.

Mechanism of Action & Pharmacokinetics 12

  • Primarily acts on mu-opioid receptors in the central nervous system (CNS) to produce analgesia.
  • Onset in 30-60 minutes (PO) and 10-15 minutes (IV), half life 2-3 hours 3
  • Binds to opioid receptors leading to inhibition of ascending pain pathways, altering the perception of and response to pain.
  • Metabolized in the liver by glucuronidation, producing dihydromorphine and dihydroisomorphine (active) and hydromorphone-3-glucuronide (inactive)
    • hydromorphone-3-glucuronide can accumulate in renal failure which can cause cognitive effects and neuroexcitation 2
  • Excreted primarily through the kidneys.

Pharmacodynamics 12

Cardiovascular

  • Can cause mild to moderate hypotension due to peripheral vasodilation.
  • Minimal effects on myocardial contractility, but may cause bradycardia in some patients.

Respiratory

  • Depresses respiratory centers in the brainstem, leading to decreased respiratory rate and minute ventilation. Often compensatory increased tidal volume occurs 1
  • Risk of respiratory depression increases with dose and concomitant use of other CNS depressants.

Indications 1

  • Management of moderate to severe pain where the use of an opioid analgesic is appropriate.
  • Often used in postoperative pain management, cancer pain, and severe acute pain.

Dosage 2

  • Oral:
    • 2 to 4 mg every 4 to 6 hours as needed for pain.
  • Intravenous (IV):
    • 0.2 to 1 mg every 2 to 3 hours as needed for pain.
    • 5-15 mcg/kg in pediatrics
  • Patient-Controlled Analgesia (PCA):
    • Initial demand dose: 0.1 to 0.2 mg IV; lockout interval typically 6 to 10 minutes.
  • Dosage should be adjusted based on the patient's response, tolerance, and severity of pain.

Contraindications 12

  • Hypersensitivity to hydromorphone or any of its components.
  • Severe respiratory depression without resuscitative equipment or monitoring.

Complications 124

  • Respiratory depression, which can be severe and life-threatening, especially in opioid-naive patients.
  • Common opioid-related side effects include nausea, vomiting, constipation, pruritus, and sedation.
  • Long-term use may lead to tolerance, physical dependence, and opioid use disorder.
  • Risk of hypotension, especially in patients with compromised blood pressure or on concomitant medications that lower blood pressure.

References

  1. Birdi T, Sullivan P. Ottawa Anesthesia Primer. Toronto, Ontario: Echo Book Publishing; 2012.  2 3 4 5 6 7

  2. @cullenBarashCullenStoelting2024 Bruce F. Cullen, Bruce F. Cullen, Barash, Cullen, and Stoelting's clinical anesthesia, 2024 Private or Broken Links
    The page you're looking for is either not available or private!

     2 3 4 5 6

  3. @pardo2017basics M. Pardo, R.D. Miller, Basics of anesthesia E-book, 2017 Private or Broken Links
    The page you're looking for is either not available or private!

  4. Ducharme, S. (2020). Hydromorphone. Anesthesia & Analgesia, 91(5): 1224-1226. DOI: 10.1097/00000539-202005000-00034.